Amgen (AMGN) EBT Margin Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Margin Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
1,755.00 |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
-3,737.00 |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
-552.00 |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
-5,950.00 |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
-3.00 |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
1,234.00 |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
372.00 |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
168.00 |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
| Mar 31, 2026 |
-3.00 |
| Dec 31, 2025 |
674.00 |
| Sep 30, 2025 |
456.00 |
| Jun 30, 2025 |
762.00 |
| Mar 31, 2025 |
2,512.00 |
| Dec 31, 2024 |
-179.00 |
| Sep 30, 2024 |
826.00 |
| Jun 30, 2024 |
-1,364.00 |
| Mar 31, 2024 |
-5,729.00 |
| Dec 31, 2023 |
-37,043.00 |
| Sep 30, 2023 |
-775.00 |
| Jun 30, 2023 |
-11.00 |
| Mar 31, 2023 |
2,953.00 |
| Dec 31, 2022 |
34,970.00 |
| Sep 30, 2022 |
382.00 |
| Jun 30, 2022 |
1,467.00 |
| Mar 31, 2022 |
-462.00 |
| Dec 31, 2021 |
149.00 |
| Sep 30, 2021 |
-221.00 |
| Jun 30, 2021 |
-2,416.00 |
| Mar 31, 2021 |
-132.00 |
| Dec 31, 2020 |
-409.00 |
| Sep 30, 2020 |
-734.00 |
| Jun 30, 2020 |
-1,329.00 |
| Mar 31, 2020 |
-1,099.00 |
| Dec 31, 2019 |
-269.00 |
| Sep 30, 2019 |
368.00 |
| Jun 30, 2019 |
-61.00 |
| Mar 31, 2019 |
-524.00 |
| Dec 31, 2018 |
-335.00 |
| Sep 30, 2018 |
-566.00 |
| Jun 30, 2018 |
101.00 |
| Mar 31, 2018 |
170.00 |
| Dec 31, 2017 |
-56.00 |
| Sep 30, 2017 |
-17.00 |
| Jun 30, 2017 |
534.00 |
| Mar 31, 2017 |
422.00 |
| Dec 31, 2016 |
442.00 |
| Sep 30, 2016 |
410.00 |
| Jun 30, 2016 |
204.00 |
| Mar 31, 2016 |
461.00 |
| Dec 31, 2015 |
1,104.00 |
| Sep 30, 2015 |
1,216.00 |
| Jun 30, 2015 |
270.00 |
| Mar 31, 2015 |
1,085.00 |
| Dec 31, 2014 |
373.00 |
| Sep 30, 2014 |
-477.00 |
| Jun 30, 2014 |
495.00 |
| Mar 31, 2014 |
-471.00 |
| Dec 31, 2013 |
-15.00 |
| Sep 30, 2013 |
228.00 |
| Jun 30, 2013 |
-411.00 |
| Mar 31, 2013 |
-266.00 |
| Dec 31, 2012 |
-562.00 |
| Sep 30, 2012 |
1,835.00 |
| Jun 30, 2012 |
30.00 |
| Mar 31, 2012 |
-108.00 |
| Dec 31, 2011 |
33.00 |
| Sep 30, 2011 |
-2,644.00 |
| Jun 30, 2011 |
-613.00 |
| Mar 31, 2011 |
-415.00 |
| Dec 31, 2010 |
-215.00 |
| Sep 30, 2010 |
-307.00 |
| Jun 30, 2010 |
318.00 |
| Mar 31, 2010 |
220.00 |